Åkesson, Julius
Ostenfeld, Ellen
Carlsson, Marcus
Arheden, Håkan
Heiberg, Einar
Funding for this research was provided by:
Vetenskapsrådet
Region Skåne
Hjärt-Lungfonden
Knut och Alice Wallenbergs Stiftelse
Lund University
Article History
Received: 5 July 2022
Accepted: 17 January 2023
First Online: 21 January 2023
Competing interests
: EH is the CTO and founder of Medviso AB that produces the software Segment that was used throughout this study. All other authors declare that they have no competing interests.